None listed
Conditions
Interventions
Drug, Medical Device : Both the experimental and control groups apply a local analgesic-anesthetic once during wound closure after bariatric surgery. The experimental group, known as the Welpass group
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study enrolled participants who satisfied the National Health Insurance criteria for bariatric surgery, which necessitates a body mass index (BMI) of =35 kg/m2 or a BMI of =30 kg/m2 with associated obesity-related complications such as hypertension, hyperlipidemia, diabetes, fatty liver and polycystic ovary syndrome. And individuals aged 19 years or older who voluntarily consented to participate in the study were included.
Exclusion criteria
Exclusion criteria: The exclusion criteria included: 1) Patients who were currently receiving, or had previously received, any investigational products, or those with medical conditions that could affect the safety and efficacy evaluation of this medical device; 2) Patients with known hypersensitivity to ropivacaine or other amide-type local anesthetics; 3) Patients experiencing severe bleeding or shock; 4) Patients with inflammation at or around the site of injection; 5) Patients suffering from sepsis; 6) Patients requiring intravenous partial anesthesia; 7) Patients who had participated in another clinical study within the past 30 days; 8) Patients considered unsuitable by the investigator for various reasons, such as lack of cooperation; and 9) Patients with contraindications to using ketorolac.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total usage of Ketorolac | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity (Numeral Rating Scale) | — |
Countries
Korea, Republic of
Contacts
Public ContactMira Yoo
Seoul National University Bundang Hospital
Outcome results
None listed